3-[(Phenylacetyl)amino]-2,6-piperidinedione hydrolysis studies with improved synthesis and characterization of hydrolysates

Journal of Pharmaceutical Sciences

Volumn 85, Issue 10, 1996, Pages 1049-1052

  Revelle, Larry K ^a   D'Avignon, D André ^b   Wilson, Joe A ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 PHENYLACETAMIDO 2,6 PIPERIDINEDIONE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CHROMATOGRAPHY; DRUG HYDROLYSIS; DRUG ISOLATION; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; NUCLEAR MAGNETIC RESONANCE;

EID: 0029847941     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js960120y     Document Type: Article

References (14)

1. Green, S. J. Am. Med. Assoc. 1992, 267, 2924-2928.
2. Burzynski, S.; Houston, R.; Waneb, H.; Green, S. J. Am. Med. Assoc. 1993, 269, 475-476.
3. Burzynski, S.; Mohabbat, M.; Burzynski, B. Drugs Exp. Clin. Res. 1984, 10, 611.
4. Burzynski, S.; Mohabbat, M.; Burzynski, B. Drugs Exp. Clin. Res. 1984, 10, 891.
5. Burzynski, S.; Hendry, L.; Mohabbat, M.; Liau, M.; Khalid, M.; Burzynski B. Proc. Int. Congr. Chemother., 13th 1983, 17, 11-14.
6. Burzynski, S.; Hai, T. Drugs of the Future 1985, 10, 103-105.
7. Burzynski, S. Recent Adv. Chemother., Proc. Int. Congr. Chemother., 14th 1985, 586-587.
8. Burzynski, S. Drugs Exp. Clin. Res. 1986, 12, 1-9.
9. Michalska, D. Spectrochim. Acta, Part A 1993, 49, 303-314.
10. Lehner, A.; Burzynski, S.; Hendry, L. Drugs Exp. Clin. Res. 1986, 12, 57-72.
11. Hendry, L.; Muldoon, T.; Burzynski, S.; Copland, J.; Lehner, A. Drugs Exp. Clin. Res. 1987, 13, 77-81.
12. Burzynski, S.; Mohabbat, M.; Lee, S. Drugs Exp. Clin. Res. 1986, 12, 11-16.
13. Ashraf, A.; Liau, M.; Mohabbat, M.; Burzynski, S. Drugs Exp. Clin. Res. 1986, 12, 37-45.
14. Lee, J.; Lee, Y; Shin, S.; Choi, B. Arch. Pharmacal Res. 1995, 18, 75-78.